. 2021 Oct 9;75(3):760–767. doi: 10.1007/s12020-021-02897-6

Table 2.

Sniffing olfactory screening test (SOST) and importance of olfaction questionnaire (IOQ) results in the two groups of patients with type 2 diabetes (with and without diabetic complications) and controls

	Patients with type 2 diabetes		Control subjects	p
	Without complications	With complication	Control subjects	p
SOST	10 (9.25–11)	9 (8–10)	11 (10–11)	0.001
IOQ	43 (35.75–50)	44 (40–50)	43 (41–44)	0.742

Median and interquartile ranges are reported (in brackets). The results of Kruskal–Wallis test are reported. Significant differences are highlighted in bold